Article

Immunogenicity and Safety of Serum-Free Rabies Vaccine (Vero Cell) for Human Use, Freeze-Dried with Different Immunization Schedules: A Randomized, Double-Blind, Active-Controlled Phase Ⅰ/Ⅲ Clinical Trial

2026-01-26

Abstract excerpt

<h4>Background: </h4> The next generation (serum-free) rabies vaccine has been under development progress and shown good safety and immunogenicity profiles. A reduced 4-dose vaccine schedule, replacing the previously recommended 5-dose schedule, has been recommended for postexposure prophylaxis (PEP) to prevent human rabies. <h4>Methods:</h4> A randomized, double-blind, active-controlled phase Ⅰ/Ⅲ clinical trial i...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 7c445ccb-bf0e-53a8-9469-7a98e81a368c
DOI: 10.20944/preprints202601.1814.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Immunogenicity and Safety of Serum-Free Rabies Vaccine (Vero Cell) for Human Use, Freeze-Dried with Different Immunization Schedules: A Randomized, Double-Blind, Active-Controlled Phase Ⅰ/Ⅲ Clinical TrialDOI 10.20944/preprints202601.1814.v1Read

Immunogenicity and Safety of Gamma, Omicron BA.4/5 and Bivalent SARS-CoV-2 RBD-based Protein Booster Vaccines in Adults Previously Immunized with Different Vaccine Platforms: a Phase II/III, Randomized, Clinical TrialSemantic proximity Read

A First in Human Trial to Evaluate the Safety and Immunogenicity of a G Protein Based Recombinant Respiratory Syncytial Virus Vaccine in Healthy Adults 18-45 YearsSemantic proximity Read

Oral vaccination of wildlife using a vaccinia–rabies-glycoprotein recombinant virus vaccine (RABORAL V-RG®): a global reviewSemantic proximity Read

Eradicate Rabies with Mass Parental Vaccination, Human Post-Exposure Prophylaxis, and Gene Therapy: A Systematic ReviewSemantic proximity Read

Developments in Rabies Vaccines: The Path Traversed from Pasteur to the Modern Era of ImmunizationSemantic proximity Read

Effect of the Third Dose of Astrazeneca Vaccine on the Ability to Generate Anti-Rbd Antibodies within Two At-Risk Populations, Geriatrics and Health Personnel in the Province of TucumánSemantic proximity Read

A comparative study on the safety and immunogenicity of purified duck embryo cell vaccine (PDEV, Vaxirab) with purified chick embryo cell vaccine (PCEC, Rabipur) and purifed vero cell rabies vaccine (PVRV, Verorab)Semantic proximity Read

A First-in-Human Trial to Evaluate the Safety and Immunogenicity of a G Protein-Based Recombinant Respiratory Syncytial Virus Vaccine in Healthy Adults 18–45 Years of AgeSemantic proximity Read

EFFECT OF THE THIRD DOSE OF ASTRAZENECA VACCINE ON THE ABILITY TO GENERATE ANTI-RBD ANTIBODIES WITHIN TWO AT-RISK POPULATIONS, GERIATRICS AND HEALTH PERSONNEL IN THE PROVINCE OF TUCUMÁNSemantic proximity Read

Inactivated rabies virus vectored SARS-CoV-2 vaccine prevents disease in a Syrian hamster modelSemantic proximity Read

Development of combined vaccines for rabies and immunocontraceptionSemantic proximity Read

Genetically modified rabies virus ERA strain is safe and induces long-lasting protective immune response in dogs after oral vaccinationSemantic proximity Read